Resistant hypertension is a common and clinically important problem in which blood pressure remains above the recommended target despite appropriate treatment with multiple antihypertensive medications.

It is important to recognize resistant hypertension because these patients have a higher risk of cardiovascular disease, stroke, heart failure, kidney disease, and other complications. However, before labeling hypertension as “resistant,” clinicians should carefully exclude inaccurate blood-pressure measurement, poor medication adherence, white-coat hypertension, and other causes of pseudoresistant hypertension.

What Is Resistant Hypertension?

Resistant hypertension is generally defined as:

Blood pressure remaining above the treatment goal despite treatment with three antihypertensive medications from complementary classes, including a diuretic, at maximally tolerated doses; or
Blood pressure controlled but requiring four or more antihypertensive medications.

The 2025 AHA/ACC guideline emphasizes confirming true resistance and evaluating for contributing medications and secondary causes of hypertension.

A typical three-drug regimen includes:

An ACE inhibitor or ARB
A long-acting calcium-channel blocker
A thiazide-type or thiazide-like diuretic

The exact combination and doses should be individualized according to kidney function, electrolytes, cardiovascular disease, age, and other clinical factors.

Why Is Resistant Hypertension Important?

Persistent uncontrolled blood pressure increases the risk of:

Stroke
Myocardial infarction
Heart failure
Chronic kidney disease
Atrial fibrillation
Peripheral arterial disease
Cardiovascular death

The 2025 AHA/ACC guideline notes that people with resistant hypertension have substantially greater cardiovascular and kidney risks than people whose hypertension responds adequately to treatment.

Therefore, resistant hypertension should prompt a systematic evaluation rather than simply adding more medications.

Pseudoresistant Hypertension: The First Thing to Exclude

Not every patient with apparently uncontrolled hypertension has true resistant hypertension.

1. Incorrect blood-pressure measurement

Blood pressure should be measured using an appropriate cuff size, with the patient seated and rested.

Important considerations include:

Appropriate cuff size
Back supported
Feet on the floor
Arm supported at heart level
No talking during measurement
Adequate rest before measurement
Repeated measurements when appropriate

Poor technique can result in falsely elevated readings.

2. White-coat effect

Some patients have high blood pressure in the clinic but normal blood pressure outside the clinic.

Home blood-pressure monitoring or 24-hour ambulatory blood-pressure monitoring (ABPM) can help distinguish true resistant hypertension from a white-coat effect. Out-of-office BP measurement is particularly important when resistant hypertension is suspected.

3. Medication nonadherence

Medication adherence should be assessed in a nonjudgmental way.

Ask about:

Missed doses
Cost of medication
Side effects
Complex dosing schedules
Availability of medications
Understanding of the treatment plan

Simplifying the medication regimen, including combination pills when appropriate, may improve adherence.

Common Causes and Risk Factors

Several factors are associated with resistant hypertension.

Lifestyle factors

High dietary sodium intake
Obesity
Physical inactivity
Excessive alcohol consumption
Poor sleep
Unhealthy diet
Smoking

Medical conditions

Chronic kidney disease
Diabetes mellitus
Obstructive sleep apnea
Primary aldosteronism
Renovascular disease
Obesity
Other forms of secondary hypertension

The 2025 AHA/ACC guideline specifically highlights resistant hypertension as an indication for evaluation for secondary causes, particularly primary aldosteronism.

Medications That Can Raise Blood Pressure

A medication review is essential.

Potential contributors include:

NSAIDs
Oral contraceptives
Systemic corticosteroids
Sympathomimetic decongestants
Some antidepressants
Stimulant medications
Calcineurin inhibitors
Erythropoiesis-stimulating agents
Some cancer therapies
Certain herbal preparations

Patients should also be asked about over-the-counter medications and supplements.

The 2025 AHA/ACC guideline recommends a careful review of medications that may interfere with blood-pressure control.

Secondary Hypertension: What Should Be Considered?

Secondary hypertension is particularly important in patients with resistant hypertension.

1. Primary Aldosteronism

Primary aldosteronism is one of the most important secondary causes to consider.

It should be suspected particularly in patients with:

Resistant hypertension
Hypokalemia
Hypertension with obstructive sleep apnea
Adrenal incidentaloma
Early-onset hypertension
Family history of early hypertension or stroke

Importantly, hypokalemia is not required for primary aldosteronism.

The 2025 AHA/ACC guideline recommends screening adults with resistant hypertension for primary aldosteronism regardless of whether hypokalemia is present.

Initial screening generally involves measurement of:

Plasma aldosterone
Renin
Aldosterone-to-renin ratio

Interpretation requires attention to medications, potassium level, posture, timing, and the laboratory’s assay-specific reference ranges.

2. Obstructive Sleep Apnea

Obstructive sleep apnea is common in patients with difficult-to-control hypertension.

Consider screening patients with:

Loud snoring
Witnessed apneas
Excessive daytime sleepiness
Obesity
Resistant hypertension

Appropriate diagnosis and treatment of sleep apnea can be an important component of overall blood-pressure management.

3. Chronic Kidney Disease

Kidney disease can both cause and result from hypertension.

Evaluation may include:

Serum creatinine
Estimated GFR
Electrolytes
Urinalysis
Urine albumin-to-creatinine ratio

The presence of CKD can also influence the selection and dosing of antihypertensive medications.

4. Renovascular Hypertension

Renal artery stenosis should be considered in selected patients, particularly when hypertension:

Develops abruptly
Becomes suddenly difficult to control
Is associated with recurrent flash pulmonary edema
Is accompanied by other clinical clues suggesting renovascular disease

Imaging should be guided by the clinical presentation rather than performed routinely in every patient.

Treatment of Resistant Hypertension

Treatment should address both the underlying causes and the antihypertensive regimen.

Step 1: Optimize Lifestyle

Lifestyle modification remains an important part of treatment.

Reduce sodium intake

Excess sodium can contribute substantially to resistant hypertension.

Patients should be encouraged to reduce:

Processed foods
Instant noodles
Salty snacks
Preserved foods
High-sodium sauces
Restaurant and fast foods

Weight management

Weight reduction can improve blood pressure and may reduce the number of medications required.

Exercise

Regular aerobic and resistance exercise can contribute to better blood-pressure control.

Limit alcohol

Alcohol reduction is appropriate for patients who consume alcohol.

Improve sleep

Adequate sleep and evaluation for obstructive sleep apnea are particularly important in patients with resistant hypertension.

Step 2: Optimize the Three-Drug Regimen

A commonly recommended foundation is:

ACE inhibitor or ARB + long-acting CCB + effective diuretic

The diuretic component deserves particular attention.

Thiazide-like diuretics such as:

Chlorthalidone
Indapamide

may provide more sustained blood-pressure control than hydrochlorothiazide in some patients.

The 2025 AHA/ACC guideline recognizes chlorthalidone and indapamide as important options in resistant hypertension.

In patients with advanced CKD or significant volume overload, a loop diuretic may be more appropriate depending on kidney function and clinical circumstances.

Step 3: Add a Mineralocorticoid Receptor Antagonist

For many patients with confirmed resistant hypertension, spironolactone is an important fourth-line option.

Typical doses used clinically include:

Spironolactone 25–50 mg once daily

The 2025 AHA/ACC guideline identifies mineralocorticoid receptor antagonists as a key treatment option in resistant hypertension, while the ESC guideline also recommends spironolactone in appropriate patients.

Spironolactone can be particularly effective when excess mineralocorticoid activity contributes to hypertension.

Important precautions

Monitor:

Serum potassium
Serum creatinine
eGFR

Hyperkalemia is an important concern, particularly in patients with CKD or those receiving renin-angiotensin system blockers.

Spironolactone can also cause:

Gynecomastia
Breast tenderness
Menstrual irregularities
Other antiandrogenic effects

Eplerenone may be considered when spironolactone is not tolerated.

Step 4: Additional Antihypertensive Therapy

If blood pressure remains uncontrolled despite optimized triple therapy and a mineralocorticoid receptor antagonist, further treatment should be individualized.

Potential options include:

Beta-blockers when clinically indicated
Alpha-blockers
Central sympatholytic agents
Other vasodilators
Additional diuretic strategies

Hydralazine or minoxidil generally require careful management because of fluid retention and sympathetic activation.

Referral to a hypertension specialist should be considered when blood pressure remains uncontrolled despite appropriate evaluation and treatment.

What About Renal Denervation?

Renal denervation (RDN) is an interventional treatment that reduces renal sympathetic nerve activity.

It is not a replacement for appropriate lifestyle measures and pharmacological treatment.

The 2025 AHA/ACC guideline recognizes renal denervation as an option for selected patients after appropriate evaluation by a multidisciplinary team, with discussion of potential benefits and procedural risks through shared decision-making.

Patient selection requires careful assessment of:

True resistant hypertension
Medication adherence
Secondary causes
Kidney and renal artery anatomy
Procedural risks
Patient preferences

A Practical Clinical Approach

When a patient presents with apparently resistant hypertension, consider the following sequence:

1. Confirm the blood pressure

Correct office measurement
Repeat measurements
Home BP monitoring
Consider ABPM

2. Confirm adherence

Ask about missed doses
Review side effects
Assess medication access and cost
Simplify treatment when possible

3. Review medications

Look for drugs and supplements that increase blood pressure.

4. Assess lifestyle factors

Evaluate:

Sodium intake
Weight
Physical activity
Alcohol
Sleep
Smoking

5. Look for secondary causes

Especially:

Primary aldosteronism
Obstructive sleep apnea
CKD
Renovascular hypertension
Other endocrine causes when clinically indicated

6. Optimize the treatment regimen

Ensure appropriate use of:

ACEi/ARB + CCB + effective diuretic

7. Add spironolactone when appropriate

Monitor potassium and kidney function.

8. Refer when necessary

Consider specialist hypertension referral for persistent uncontrolled blood pressure, suspected secondary hypertension, complex comorbidities, or consideration of device-based treatment.

Key Take-Home Messages

Resistant hypertension does not simply mean “add another medication.”

The most important principles are:

Confirm that hypertension is truly resistant.
Exclude inaccurate BP measurement and white-coat hypertension.
Assess medication adherence carefully.
Review medications and substances that can raise BP.
Search for secondary hypertension, especially primary aldosteronism.
Optimize the core regimen of an ACE inhibitor/ARB, calcium-channel blocker, and appropriate diuretic.
Consider spironolactone as an important fourth-line treatment when appropriate.
Monitor kidney function and potassium carefully.
Address obesity, dietary sodium, sleep apnea, physical inactivity, and other modifiable factors.
Refer difficult cases to a hypertension specialist and consider renal denervation only in appropriately selected patients.

When Should a Patient Seek Urgent Medical Attention?

A very high blood pressure reading requires assessment in the context of symptoms and evidence of acute target-organ injury.

Urgent evaluation is particularly important when markedly elevated BP is accompanied by symptoms such as:

Chest pain
Severe shortness of breath
New neurological deficits
Confusion
Severe headache with neurological symptoms
Visual disturbance
Seizure
Signs of acute heart failure

The goal is not simply to lower the number on the blood-pressure monitor, but to determine whether acute target-organ damage is occurring.

Conclusion

Resistant hypertension is a complex but treatable form of hypertension. Successful management requires a systematic approach rather than simply adding medications.

Confirm the diagnosis, exclude pseudoresistance, evaluate adherence and interfering medications, identify secondary causes, optimize lifestyle measures, and use evidence-based multidrug therapy.

For many patients, appropriate use of a thiazide-like diuretic and addition of a mineralocorticoid receptor antagonist such as spironolactone can substantially improve blood-pressure control. Patients who remain uncontrolled despite comprehensive management may benefit from specialist evaluation and, in selected cases, consideration of renal denervation.

Early recognition and systematic treatment of resistant hypertension can help reduce the long-term risk of cardiovascular and kidney complications.

References

2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults.
2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension.
Carey RM, et al. Resistant Hypertension: Detection, Evaluation, and Management. American Heart Association Scientific Statement. Hypertension. 2018;72:e53–e90.